Ishita Drugs and Industries Limited

ISHITADR6

INE806D01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-07-12 am EDT			5-day change	1st Jan Change
68.97 ^INR	+2.13%		+4.50%	-4.13%

May. 30	Ishita Drugs and Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
Feb. 13	Ishita Drugs and Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Ishita Drugs and Industries Limited Announces Appointment of Srushti Pandya as Company Secretary and Compliance Officer, Effective February 4, 2021

February 04, 2021 at 08:12 am EST

Ishita Drugs and Industries Limited announced appointment of Srushti Pandya as Company secretary cum compliance officer, effective February 4, 2021.

Latest news about Ishita Drugs and Industries Limited

Ishita Drugs and Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 30	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-12	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-30	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23-02-14	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-13	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-02	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the First quarter Ended June 30, 2021	21-08-13	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-30	CI
Ishita Drugs and Industries Limited Announces Appointment of Srushti Pandya as Company Secretary and Compliance Officer, Effective February 4, 2021	21-02-04	CI
Ishita Drugs and Industries Limited Announces Resignation of Vijay Shah from the Post of Company Secretary and Compliance Officer	21-02-04	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-04	CI
Ishita Drugs and Industries Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-09	CI
Ishita Drugs & Industries Limited Appoints Vijay Shah as Company Secretary and Compliance Officer	20-08-31	CI
Ishita Drugs & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	20-08-13	CI
Ishita Drugs & Industries Limited Accepts Resignation of Prakash Ranjan Rastogi from the Position of Independent Non-Executive Director	20-06-30	CI
Ishita Drugs & Industries Limited Announces Resignation of Niharika Shah as Company Secretary and Compliance Officer	20-06-30	CI
Ishita Drugs & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	20-06-30	CI
Ishita Drugs & Industries Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-11	CI
Ishita Drugs & Industries Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-11-12	CI
Ishita Drugs & Industries Limited Approves Resignation of Shyamkumar Agrawal from the Position of Independent Director	19-11-12	CI
Ishita Drugs and Industries Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2019	19-08-13	CI

Chart Ishita Drugs and Industries Limited

Duration

Period

Chart Ishita Drugs and Industries Limited

More charts

Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ISHITA DRUGS AND INDUSTRIES LIMITED	-4.13%	2.47M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B
PFIZER, INC.	+0.45%	164B